Sarah Profitt, PharmD, BCOP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Consultant
    Date added:
    04/07/2025
    Date updated:
    04/07/2025
    Relationship end date:
    09/22/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Blueprint Medicines
    Topic:
    Advisory Board
    Date added:
    04/07/2025
    Date updated:
    04/07/2025
    Relationship end date:
    01/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lilly and Company
    Topic:
    Advisory Board
    Date added:
    04/07/2025
    Date updated:
    04/07/2025
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Rigel Pharmaceuticals
    Topic:
    Advisory Board
    Date added:
    04/07/2025
    Date updated:
    04/07/2025
    Relationship end date:
    09/26/2025
Return to Case-Based Insights on Hematologic Malignancies